arrow
Back
G

Gavin Giovannoni

Queen Mary University of London

104H-index
1.3KPaper Count
4.3WCitation Count
Published Papers 406
Publication Date
Predictors of Multiple Sclerosis After Clinically Isolated Syndrome: A Systematic Review and Meta-Analysis
err2026-08-20
err0
errOAAI
errMaría Paula Zafra-Sierra; Carolina Ferreira-Atuesta; Daniela Sofía Rodríguez; Jairo Gaitán; Susana Otero; Mar Tintoré; Fred Lublin; Gavin Giovannoni; Jaime Toro; Saúl Reyes
errShare
errSave
Progression to Wheelchair in Secondary Progressive Multiple Sclerosis and Impact of Siponimod: Post Hoc Analyses From the EXPAND Study
err2026-06-08
err0
errOAAI
errPatrick Vermersch; Sophie Arnould; Ralf Gold; Ludwig Kappos; Robert Fox; Amit Bar-Or; Bruce A. C. Cree; Soudeh Ansari; Daniela Piani Meier; Goeril Karlsson; Nicolas Rouyrre; Gavin Giovannoni
errShare
errSave
errShare
errSave
Multiple sclerosis and autoimmunity: learnings from post-streptococcal autoimmunity
err2026-02-23
err0
errOAAI
errBenjamin Michael Bloom; Olivia Payne; Ester Valero-Hernandez; Angray S. Kang; Bavneet Kaur Singh; David Baker; Kathryn Harris; Teresa Cutino-Moguel; Ian Butler; David L. Selwood; Louisa K. James; Gavin Giovannoni
errShare
errSave
Post-streptococcal Autoimmunity and Its Relevance to Epstein-Barr virus as the Potential Cause of Multiple Sclerosis
err2026-02-01
err0
PREAI
errGiovannoni, Gavin; Payne, Olivia; Valero-Hernandez, Ester; Kang, Angray S.; Singh, Bavneet Kaur; Baker, David; Harris, Kathryn; Cutino-Moguel, Teresa; James, Louisa K.; Bloom, Benjamin Michael
errShare
errSave
Advancing Care in Myasthenia Gravis: What Can We Learn From the Multiple Sclerosis Community?
err2025-12-03
err0
errOAAI
errJames F. Howard; Mona Sadeghian; Natasa Savic; Gavin Giovannoni
errShare
errSave
The Brainstem Signature of Multiple Sclerosis: Predictable Lesions, Consistent Syndromes
err2025-12-03
err0
errOAAI
errMohammad Wafa; Khalid Nuh; Gavin Giovannoni; Klaus Schmierer; Sharmilee Gnanapavan; Ruth Dobson; Monica Marta; Maria Papachatzaki; Benjamin Turner; Thomas Campion; Ashok Adams; Anant Krishnan; Alexandros Chatzistefanou; Bader Mohamed; Ahmed Hashis
errShare
errSave
Brain Age
err2025-11-28
err0
PREAI
errRodney Lea; Stasson Lea; Gavin Giovannoni; Chris Hawkes; Michael Levy; E. Ann Yeh; Jeannette Lechner-Scott
errShare
errSave
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial
err2025-10-01
err0
errOAAI
errJeremy Chataway; Thomas Williams; James Blackstone; Nevin John; Marie Braisher; Floriana De Angelis; Alessia Bianchi; Alberto Calvi; Anisha Doshi; Sean Apap Mangion; Charles Wade; Ekaterina Bordea; Rachel Merry; Gil Barton; Dawn Lyle; Elisabeth Jarman; Don Mahad; Abdullah Shehu; Tarunya Arun; Gavin McDonnell; Ruth Geraldes; Matthew Craner; Charles Hillier; Jeban Ganesalingam; Leonora Fisniku; Jeremy Hobart; Cord Spilker; Neil P Robertson; Seema Kalra; Stefano Pluchino; Sreedharan Harikrishnan; Miriam Mattoscio; Timothy Harrower; Carolyn Young; Martin Lee; Suresh Kumar Chhetri; Fayyaz Ahmed; David Rog; Eli Silber; Paul Gallagher; Martin Duddy; Agne Straukiene; Richard Nicholas; Claire Rice; Susan Tebbs; Annie Hawton; Rachael Hunter; Gavin Giovannoni; Olga Ciccarelli; Judy Beveridge; Stuart Nixon; Alan J Thompson; John Greenwood; Owen R Pearson; Nikos Evangelou; Basil Sharrack; Ian Galea; Emma Gray; Sue Pavitt; Siddharthan Chandran; Helen L Ford; Chris Frost; Jennifer M Nicholas
errShare
errSave
When does multiple sclerosis start?
err2025-09-02
err0
PREAI
errGavin Giovannoni; Christopher H Hawkes; Jeannette Lechner-Scott; Michael Levy; E. Ann Yeh
errShare
errSave
Gaps and discordance in assessment of PIRA identified between HCPs and people with MS: Results of international surveys
err2025-08-18
err0
errOAAI
errBenjamin Greenberg; Gavin Giovannoni; Kerstin Hellwig; Martyna Dackiewicz; Gareth Turley; Jiwon Oh
errShare
errSave
Treatment of First and Subsequent Attacks in Multiple Sclerosis
err2025-08-06
err0
PREAI
errChristopher H Hawkes; Gavin Giovannoni; Jeanette Lechner-Scott; Michael Levy; Ann Yeh
errShare
errSave
The P42 epitope in MOG associated disorders: understanding regional variations and predictive value
err2025-07-14
err0
PREAI
errE. Ann Yeh; Jeannette Lechner-Scott; Chris Hawkes; Michael Levy; Gavin Giovannoni
errShare
errSave
The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis
errBrain
IF11.7
err2025-05-06
err0
errOAAI
errGavin Giovannoni; Louisa James; Adekunle A Adeniran; Julian Gold; Lawrence S Young; David L Selwood; David Baker; Ruth Dobson
errShare
errSave
Identifying axonal injury through the eye: can the cornea provide new clues to axonal injury in MS?
err2025-05-01
err0
PREAI
errYeh, E. Ann; Lechner-Scott, Jeannette; Levy, Michael; Hawkes, Chris; Giovannoni, Gavin
errShare
errSave
Brain health – time matters: multiple sclerosis, neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and related conditions. 2024 report
err2025-04-19
err0
errOAAI
errHelmut Butzkueven; Sofia Arkelsten; Giancarlo Comi; Kathleen Costello; Michael Devlin; Jelena Drulovic; Emma Gray; Jodi Haartsen; Anne Helme; Jana Hlavácová; Elisabeth Kasilingam; Yaou Liu; Thomas Mathew; Saúl Reyes; Jérôme de Sèze; Mitzi J Williams; Gavin Giovannoni
errShare
errSave
IS MULTIPLE SCLEROSIS A MICROGLIOPATHY?
err2025-04-01
err0
PREAI
errHawkes, Christopher H.; Giovannoni, Gavin; Lechner-Scott, Jeanette; Levy, Michael; Yeh, Ann
errShare
errSave
Infectious mononucleosis is a more realistic target for preventing multiple sclerosis
err2025-03-01
err0
PREAI
errGiovannoni, Gavin; Hawkes, Christopher H.; Lechner-Scott, Jeannette; Yeh, E. Ann; Levy, Michael
errShare
errSave
Is there truly no progression in NMOSD and MOGAD?
err2025-02-01
err0
PREAI
errLechner-Scott, J.; Giovannoni, G.; Ch, Hawkes; Levy, M.; Ea, Yeh
errShare
errSave